Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Selective serotonin reuptake inhibitors and venlafaxine in pregnancy: Changes in drug disposition

14 Jul 2017

Abstract excerpt

BACKGROUND: Pregnancy may cause changes in drug disposition. The clinical consequences may be profound and even counterintuitive; in some cases pregnant women may need more than twice their usual drug dose in order to maintain therapeutic drug levels. For antidepressants, evidence on drug disposition in pregnancy is scarce. The aim of this study was to determine the effects of pregnancy on serum levels of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Maternal Mental Health During Pregnancy and Postpartum
Share to Pregnancy and Medication Impact
Share to Treatment of Major Depression

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28708853
DOI: 10.1371/journal.pone.0181082

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Selective serotonin reuptake inhibitors and venlafaxine in pregnancy: Changes in drug dispositionPMID 28708853Read ↗

Precision dosing of venlafaxine during pregnancy: a pharmacokinetics modelling approach.Semantic proximity Read ↗

Concentrations of Fluoxetine Enantiomers Decline During Pregnancy and Increase After Birth.Semantic proximity Read ↗

Effect of cytochrome P450 2D6 genotype on maternal paroxetine plasma concentrations during pregnancy.Semantic proximity Read ↗

Therapeutic drug monitoring of psychoactive drugs during pregnancy in the genomic era: challenges and opportunities.Semantic proximity Read ↗

Breastfeeding during maternal antidepressant treatment with serotonin reuptake inhibitors: infant exposure, clinical symptoms, and cytochrome p450 genotypes.Semantic proximity Read ↗

Dose of selective serotonin uptake inhibitors across pregnancy: Clinical implicationsSemantic proximity Read ↗

Risks associated with antidepressants in patients with hypertension during pregnancy: a retrospective cohort studySemantic proximity Read ↗

Clinical implications of selective serotonin reuptake inhibitors-selective serotonin norepinephrine reuptake inhibitors pharmacogenetics during pregnancy and lactation.Semantic proximity Read ↗

Associations between Medication Use and Restless Legs Syndrome in Pregnancy among Nulliparous Individuals: A Secondary Analysis of the nuMoM2b Study.Semantic proximity Read ↗

SLC6A2 and SLC6A4 variants interact with venlafaxine serum concentrations to influence therapy outcome.Semantic proximity Read ↗

Precision dosing-based optimisation of paroxetine during pregnancy for poor and ultrarapid CYP2D6 metabolisers: a virtual clinical trial pharmacokinetics study.Semantic proximity Read ↗

Pharmacokinetic Changes and Seizure Outcomes in Pregnant Women Taking Second-Generation Antiepileptic DrugsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.